Revolution Medicine has wowed investors and analysts by announcing dazzling data from its Phase III RASolute 302 trial ...
A Cell Perspective argues that generative AI models could help tackle cancer’s multiscale, multimodal complexity by ...
CStone Pharmaceuticals ('CStone,' HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of therapies for oncology, immunology, inflammation, and other key ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results